Medical Specialty >> Oncology
Cancer May Soon Replace Heart Disease as Leading Killer of Affluent Americans
5:00 PM CST.
By Steven ReinbergHealthDay Reporter Read article
- Doctors Aren’t Promoting Breastfeeding’s Cancer-Protection Benefit
- Mammograms Do Save Lives: Study
- The Bigger the Brain, the Bigger the Tumor Risk?
- HPV Vaccination Rates Continue to Lag in U.S.
JOURNAL UPDATE
Progress Toward Goals in Global Health Is Slowing
12:00 PM CST. Seven articles published in the The Lancet address different aspects of the global burden…- Genetic Test Helps ID Benign Versus Malignant Thyroid Nodules
- Income, Lifestyle May Contribute to Disparity in Cancer Deaths
- Improved Long-Term Pregnancy Outcomes for Goserelin + Chemo
MONTHLY JOURNAL SUMMARY
October 2018 Briefing - Hematology & Oncology
November 01, 2018. The Monthly Journal Summary is a single article covering the most important journal articles published in the previous 30 days.
FEATURED ARTICLES
Rucaparib Maintenance Therapy Improves PFS in Platinum-sensitive Ovarian Cancer - The ARIEL3 Trial
Robert L. Coleman, MD.
Professor Robert L. Coleman M.D., FACOG, FACS discusses the implications of data from the Phase 3 ARIEL3 trial of the novel PARP inhibitor rucaparib as maintenance therapy in patients with platinum-sensitive ovarian cancer. Professor Coleman is the Vice Chair of Clinical Research in the Department of…
Characterization of patients with ovarian carcinoma who respond to the PARP inhibitor rucaparib
Elizabeth M. Swisher, MD.
Dr. Elizabeth M. Swisher comments on the implications of new data from the ARIEL2 trial, an ongoing Phase 2 trial of the novel PARP inhibitor rucaparib in relapsed, high-grade serous or endometrioid ovarian cancer. The new results offer an important insight into the genetic mechanisms behind tumor sensitivity…
Bert Vogelstein explains cancer and the unavoidable replicative mutations
Bert Vogelstein, MD.
Investigators at Johns Hopkins University in Baltimore used complex mathematical modeling to track mutations driving abnormal cell growth for 32 types of cancer. From their calculations, the researchers believe that the bulk of cancers are caused by random DNA copying errors (replicative mutations).…
MEDICAL FOCUS
Breast cancer
By Tamer M. Fouad, M.D. Breast cancer is a cancer that starts in the cells of the breast. Worldwide, breast cancer is the second most common type of cancer after lung cancer (11.9%…
DISCUSSION
RE: Investigational Topical Minocycline Gel for Acne Advances to Phase III Development
By MrRobinGreat articles. learnt a lot from it.
